Novo Nordisk (NVO)
(Delayed Data from NYSE)
$132.46 USD
-0.17 (-0.13%)
Updated Aug 1, 2024 04:00 PM ET
After-Market: $132.12 -0.34 (-0.26%) 7:58 PM ET
3-Hold of 5 3
C Value A Growth D Momentum B VGM
Brokerage Reports
0 items in cart
Novo Nordisk A/S [NVO]
Reports for Purchase
Showing records 181 - 196 ( 196 total )
Company: Novo Nordisk A/S
Industry: Large Cap Pharmaceuticals
Company: Novo Nordisk A/S
Industry: Large Cap Pharmaceuticals
Company: Novo Nordisk A/S
Industry: Large Cap Pharmaceuticals
Company: Novo Nordisk A/S
Industry: Large Cap Pharmaceuticals
Company: Novo Nordisk A/S
Industry: Large Cap Pharmaceuticals
Company: Novo Nordisk A/S
Industry: Large Cap Pharmaceuticals
Company: Novo Nordisk A/S
Industry: Large Cap Pharmaceuticals
Company: Novo Nordisk A/S
Industry: Large Cap Pharmaceuticals
Company: Novo Nordisk A/S
Industry: Large Cap Pharmaceuticals
Company: Novo Nordisk A/S
Industry: Large Cap Pharmaceuticals
Company: Novo Nordisk A/S
Industry: Large Cap Pharmaceuticals
Company: Novo Nordisk A/S
Industry: Large Cap Pharmaceuticals
Company: Novo Nordisk A/S
Industry: Large Cap Pharmaceuticals
Company: Novo Nordisk A/S
Industry: Large Cap Pharmaceuticals
Company: Novo Nordisk A/S
Industry: Medical - Drugs
4Q 09 Revenues and operating performance were in line with our expectations
Provider: IIR GROUP
Analyst: KHAN F